Dermatologists' Educational Demonstration for Epiduo Application

N/ACompletedNCT02192632

Seoul National University Hospital85 enrolled

Overview

The purpose of this study is to evaluate the efficacy and tolerability of this combination gel compared with BPO monotherapy in Korean patients, and test clinical practicability of dermatologists' educational demonstration for how to apply this gel in reducing uncomfortable irritations.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Facial Acne Local Adverse Effects

Interventions

Epiduo once daily with detailed instruction for how to apply itDRUG

Epiduo- once daily, simple instruction for applicationDRUG

BPO once dailyDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * mild to moderate acne were evaluated by Leeds revised acne grade from 2 to 6 * age: 18-40 Exclusion Criteria: * pregnancy * mental illness * intake of oral isotretinoin within 6 months * application of the other oral or topical acne medications * chemical peeling or light based treatments within 6 weeks.

Locations (1)

Dermatology, Seoul National University

Seoul, Joungro, South Korea

Outcomes

Primary Outcomes

Percentile reduction of non-inflammatory & inflammatory acne lesions

Measurement of decreases in both non-inflammatory \& inflammatory acne lesions

Time frame: 12 weeks

Secondary Outcomes

Total number of local irriation effect counts (erythema, scaling, dryness, itching)

Calcuation of total number of local irriation effect counts (erythema, scaling, dryness, itching)

Time frame: 12 week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.